Clearstead Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$69	Buy	+9	New	+$69	﹤0.01%	2645
2023 Q4	–	Sell	-5,064	Closed	-$56.6K	–	1556
2023 Q3	$56.6K	Buy	+5,064	New	+$56.6K	﹤0.01%	864
2022 Q3	–	Sell	-5,064	Closed	-$239K	–	1272
2022 Q2	$239K	Hold	5,064	–	–	0.02%	350
2022 Q1	$360K	Hold	5,064	–	–	0.02%	312
2021 Q4	$379K	Hold	5,064	–	–	0.03%	289
2021 Q3	$288K	Hold	5,064	–	–	0.02%	316
2021 Q2	$223K	Hold	5,064	–	–	0.02%	329
2021 Q1	$250K	Hold	5,064	–	–	0.02%	303
2020 Q4	$213K	Hold	5,064	–	–	0.02%	313
2020 Q3	$232K	Hold	5,064	–	–	0.02%	264
2020 Q2	$254K	Hold	5,064	–	–	0.03%	240
2020 Q1	$260K	Hold	5,064	–	–	0.04%	208
2019 Q4	$313K	Hold	5,064	–	–	0.04%	218
2019 Q3	$304K	Hold	5,064	–	–	0.04%	214
2019 Q2	$427K	Hold	5,064	–	–	0.06%	184
2019 Q1	$484K	Hold	5,064	–	–	0.07%	173
2018 Q4	$359K	Hold	5,064	–	–	0.06%	190
2018 Q3	$433K	Hold	5,064	–	–	0.06%	168
2018 Q2	$587K	Hold	5,064	–	–	0.08%	133
2018 Q1	$410K	Hold	5,064	–	–	0.06%	154
2017 Q4	$297K	Hold	5,064	–	–	0.04%	179
2017 Q3	$237K	Buy	+5,064	New	+$237K	0.03%	218